Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260
Follow us on:
Contract Pharma Conference

Sharp Expands Autoinjector and Pen Assembly Capacity in U.S. and EU 

 
Sharp Expands Autoinjector and Pen Assembly Capacity in U.S. and EU 

Additional device assembly and cold storage capabilities strengthen Sharp’s global clinical-to-commercial support for injectable programs.
Read More >>

Headlines

Breaking News

Jones Healthcare Group Acquires Ontario Thermoforming Facility

The process is already integral, Jones Healthcare says, to its medication adherence packaging.

Breaking News

Altasciences Completes R&D Lab Expansion in Pennsylvania

The company adds nearly 800 square feet of new laboratory space.

Breaking News
Collaborations & Alliances

Lilly, Resilience to Invest $750M in Ohio Manufacturing

The expansion will add KwikPen device production and create at least 400 high-skilled jobs in the Cincinnati region.

Breaking News

Federal Equipment Announces Turnkey Sale of Denison Pharmaceuticals Facility

The 104,000-square-foot Rhode Island operation includes pharmaceutical processing, filling, packaging and laboratory capabilities.

Breaking News
Collaborations & Alliances

Thermo Fisher Adds KinetiSol Technology at U.S. Drug Sites

Thermo Fisher expands its oral solid dose capabilities with AustinPx's solvent-free dispersion technology.

Breaking News

Piramal Pharma Solutions Expands Peptide API Facility

Adds new spray drying suite with Band 5 containment capacity at its dedicated peptide facility in Turbhe, India.

Breaking News
Collaborations & Alliances

Bora and Onconic Ink Manufacturing Pact for US Acid Blocker Tablet Clinical Development

Jaqbo potassium-competitive acid blocker tablets for gastroesophageal reflux disease were approved in Korea in 2024.